Effect of lidoflazine (R 7904) on uptake and release of serotonin by human platelets in vitro.
D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000494:pharmacology; D002247:Carbon Isotopes; D004176:Dipyridamole / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006801:Humans; D066298:In Vitro Techniques; D008013:Lidoflazine / Q000494:pharmacology; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D012701:Serotonin / Q000097:blood*; D013696:Temperature; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology*
D002247:Carbon Isotopes; D010879:Piperazines; D014665:Vasodilator Agents; D012701:Serotonin; D004176:Dipyridamole; D010208:Papaverine; D008013:Lidoflazine; D002118:Calcium